Emerging New Approaches for the Treatment of Acute Promyelocytic Leukemia

Por Park, Jae, Jurcic, Joseph G., Rosenblat, Todd, Tallman, Martin S.
Publicado em 2011

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

Por Park, Jae H., Qiao, Baozhen, Panageas, Katherine S., Schymura, Maria J., Jurcic, Joseph G., Rosenblat, Todd L., Altman, Jessica K., Douer, Dan, Rowe, Jacob M., Tallman, Martin S.
Publicado em 2011

Sequential Cytarabine and Alpha-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

Por Rosenblat, Todd L., McDevitt, Michael R., Mulford, Deborah A., Pandit-Taskar, Neeta, Divgi, Chaitanya R., Panageas, Katherine S., Heaney, Mark L., Chanel, Suzanne, Morgenstern, Alfred, Sgouros, George, Larson, Steven M., Scheinberg, David A., Jurcic, Joseph G.
Publicado em 2010

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Por Brentjens, Renier, Davila, Marco L, Riviere, Isabelle, Park, Jae, Wang, Xiuyan, Cowell, Lindsay G, Bartido, Shirley, Stefanski, Jolanta, Taylor, Clare, Olszewska, Malgorzata, Borquez-Ojeda, Oriana, Qu, Jinrong, Wasielewska, Teresa, He, Qing, Bernal, Yvette, Rijo, Ivelise V, Hedvat, Cyrus, Kobos, Rachel, Curran, Kevin, Steinherz, Peter, Jurcic, Joseph, Rosenblat, Todd, Maslak, Peter, Frattini, Mark, Sadelain, Michel
Publicado em 2013